These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 29235470)
1. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma. Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355 [TBL] [Abstract][Full Text] [Related]
3. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness. Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
5. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling. Peng R; Zhang PF; Zhang C; Huang XY; Ding YB; Deng B; Bai DS; Xu YP Cancer Med; 2018 Mar; 7(3):796-808. PubMed ID: 29446253 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma. Dong L; Xie L; Li M; Dai H; Wang X; Wang P; Zhang Q; Liu W; Hu X; Zhao M Sci Rep; 2019 Oct; 9(1):14854. PubMed ID: 31619714 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517 [TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway. Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691 [TBL] [Abstract][Full Text] [Related]
9. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma. Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137 [TBL] [Abstract][Full Text] [Related]
10. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma. Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496 [TBL] [Abstract][Full Text] [Related]
11. COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma. Lang Q; Xiao P; Zhao M; Liang D; Meng Q; Pei T Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1247-1256. PubMed ID: 33166992 [TBL] [Abstract][Full Text] [Related]
12. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383 [TBL] [Abstract][Full Text] [Related]
14. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways. Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612 [TBL] [Abstract][Full Text] [Related]
15. B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma. Cheng R; Chen Y; Zhou H; Wang B; Du Q; Chen Y APMIS; 2018 May; 126(5):396-402. PubMed ID: 29696716 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer. Huang H; Li C; Ren G Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458 [TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
18. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598 [TBL] [Abstract][Full Text] [Related]
19. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis. Yamaoka R; Ishii T; Kawai T; Yasuchika K; Miyauchi Y; Kojima H; Katayama H; Ogiso S; Fukumitsu K; Uemoto S J Surg Oncol; 2018 Sep; 118(4):664-674. PubMed ID: 30196535 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival. Shan ZG; Yan ZB; Peng LS; Cheng P; Teng YS; Mao FY; Fan K; Zhuang Y; Zhao YL J Immunol Res; 2021; 2021():6613247. PubMed ID: 33763491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]